These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 6722774

  • 21. Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
    Ali-Osman F, Giblin J, Dougherty D, Rosenblum ML.
    Cancer Res; 1987 Jul 15; 47(14):3718-24. PubMed ID: 2954633
    [Abstract] [Full Text] [Related]

  • 22. Sister chromatid exchange induction in patients with anaplastic gliomas undergoing treatment with radiation plus diaziquone or 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kligerman AD, Erexson GL, Wilmer JL, Schold SC.
    Cancer Res; 1987 Jan 15; 47(2):631-5. PubMed ID: 3791247
    [Abstract] [Full Text] [Related]

  • 23. Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma.
    Maral J, Poisson M, Pertuiset BF, Mashaly P, Weil M, Jacquillat C, Grillo-Lopez AJ.
    J Neurooncol; 1985 Jan 15; 3(3):245-9. PubMed ID: 4056853
    [Abstract] [Full Text] [Related]

  • 24. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
    Geoerger B, Kerr K, Tang CB, Fung KM, Powell B, Sutton LN, Phillips PC, Janss AJ.
    Cancer Res; 2001 Feb 15; 61(4):1527-32. PubMed ID: 11245461
    [Abstract] [Full Text] [Related]

  • 25. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
    Schold SC, Kokkinakis DM, Rudy JL, Moschel RC, Pegg AE.
    Cancer Res; 1996 May 01; 56(9):2076-81. PubMed ID: 8616853
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K.
    Clin Cancer Res; 1999 Jul 01; 5(7):1905-17. PubMed ID: 10430098
    [Abstract] [Full Text] [Related]

  • 28. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
    Szmigiero L, Erickson LC, Ewig RA, Kohn KW.
    Cancer Res; 1984 Oct 01; 44(10):4447-52. PubMed ID: 6467204
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
    Peterson JK, Tucker C, Favours E, Cheshire PJ, Creech J, Billups CA, Smykla R, Lee FY, Houghton PJ.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6950-8. PubMed ID: 16203787
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A, Shi Q, Morris D, Wilcox ME, Brasher PM, Rewcastle NB, Shalinsky D, Zou H, Appelt K, Johnston RN, Yong VW, Edwards D, Forsyth P.
    Clin Cancer Res; 1999 Apr 01; 5(4):845-54. PubMed ID: 10213221
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.